Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
Abstract
Authors
A. Sole J.L. Poveda R.M. Giron M.C. Prados Gracia J. De M.Á. Casado